Taken together, the data from multiple models of Wnt‐addicted cancers demonstrate that inhibition of Wnt signaling sensitizes cells to the PARP inhibitor olaparib by creating a BRCA‐like state via downregulation of HR and FA pathways. The gene discussed is PARP1; the disease is cancer.